搜尋
Neurosense Therapeutics Ltd
NRSN添加自選
0.723USD
+0.003+0.42%
收盤 07/01, 16:00（美東）報價延遲15分鐘
23.54M總市值
虧損本益比TTM
關於 Neurosense Therapeutics Ltd 公司
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Neurosense Therapeutics Ltd簡介
公司代碼NRSN
公司名稱Neurosense Therapeutics Ltd
上市日期Dec 09, 2021
CEOBen-Noon (Alon)
員工數量15
證券類型Ordinary Share
年結日Dec 09
公司地址11 Hamenofim St.
城市HERZLIYA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編4672562
電話97297996183
網址https://www.neurosense-tx.com/
公司代碼NRSN
上市日期Dec 09, 2021
CEOBen-Noon (Alon)
Neurosense Therapeutics Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
常見問題
Neurosense Therapeutics Ltd的前五大股東是誰？
Neurosense Therapeutics Ltd的前五大股東如下：Mr. Alon Ben-Noon
有多少機構持有Neurosense Therapeutics Ltd(NRSN)的股份？
截至2026Q1，共有33家機構持有Neurosense Therapeutics Ltd的股份，合計持有的股份價值約為367.79K，占公司總股份的1.04% 。與2025Q4相比，機構持股有所增加，增幅為-2009158.00。